Stock Track | Ginkgo Bioworks Plummets 5.32% as Baby Switching Allegations Surface at Hospital

Stock Track12-13

Ginkgo Bioworks Holdings Inc. (DNA), a leading synthetic biology company, witnessed a 5.32% plummet in its stock price on Friday, amidst allegations of a potential baby switching incident at the RS Islam Cempaka Putih hospital.

The stock's decline followed reports of a father, identified as MR, suspecting that the baby he received after his wife's delivery was not their biological child. MR claimed discrepancies in the physical appearance and measurements of the baby compared to the birth certificate details.

While the hospital has denied any baby switching incident, the allegations raise concerns over potential DNA mixups and mishandling of sensitive biological samples. As a biotechnology firm specializing in DNA engineering and synthetic biology, such incidents could potentially damage Ginkgo Bioworks' reputation and investor confidence in the company's operations and practices.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1108905998?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-13 23:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108905998","market":"us","top_or_hot":-1,"title":"Stock Track | Ginkgo Bioworks Plummets 5.32% as Baby Switching Allegations Surface at Hospital","media":"Stock Track","content":"<p>Ginkgo Bioworks Holdings Inc. (DNA), a leading synthetic biology company, witnessed a 5.32% plummet in its stock price on Friday, amidst allegations of a potential baby switching incident at the RS Islam Cempaka Putih hospital.</p>\n\n<p>The stock's decline followed reports of a father, identified as MR, suspecting that the baby he received after his wife's delivery was not their biological child. MR claimed discrepancies in the physical appearance and measurements of the baby compared to the birth certificate details.</p>\n\n<p>While the hospital has denied any baby switching incident, the allegations raise concerns over potential DNA mixups and mishandling of sensitive biological samples. As a biotechnology firm specializing in DNA engineering and synthetic biology, such incidents could potentially damage Ginkgo Bioworks' reputation and investor confidence in the company's operations and practices.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Ginkgo Bioworks Plummets 5.32% as Baby Switching Allegations Surface at Hospital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Ginkgo Bioworks Plummets 5.32% as Baby Switching Allegations Surface at Hospital\n</h2>\n\n<h4 class=\"meta\">\n\n2024-12-13 23:06 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Ginkgo Bioworks Holdings Inc. (DNA), a leading synthetic biology company, witnessed a 5.32% plummet in its stock price on Friday, amidst allegations of a potential baby switching incident at the RS ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DNA","symbol_name":"Ginkgo Bioworks Holdings Inc.","start_time":0,"source_url":"","article_id":"1108905998","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108905998","pubTimestamp":1734102382,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Ginkgo Bioworks Holdings Inc. , a leading synthetic biology company, witnessed a 5.32% plummet in its stock price on Friday, amidst allegations of a potential baby switching incident at the RS Islam Cempaka Putih hospital.The stock's decline followed reports of a father, identified as MR, suspecting that the baby he received after his wife's delivery was not their biological child. MR claimed discrepancies in the physical appearance and measurements of the baby compared to the birth certificate ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DNA":"Ginkgo Bioworks Holdings Inc."},"translate_title":"由于医院出现婴儿转换指控，Ginkgo Bioworks股价暴跌5.32%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DNA":1},"content_text":"Ginkgo Bioworks Holdings Inc. (DNA), a leading synthetic biology company, witnessed a 5.32% plummet in its stock price on Friday, amidst allegations of a potential baby switching incident at the RS Islam Cempaka Putih hospital.\nThe stock's decline followed reports of a father, identified as MR, suspecting that the baby he received after his wife's delivery was not their biological child. MR claimed discrepancies in the physical appearance and measurements of the baby compared to the birth certificate details.\nWhile the hospital has denied any baby switching incident, the allegations raise concerns over potential DNA mixups and mishandling of sensitive biological samples. As a biotechnology firm specializing in DNA engineering and synthetic biology, such incidents could potentially damage Ginkgo Bioworks' reputation and investor confidence in the company's operations and practices.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1108905998"}